Skip to main content
Log in

Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

In a multicentre study anticardiolipin antibodies of the IgG and IgM isotypes were measured by a solid phase enzyme immunoassay in 368 patients with systemic lupus erythematosus (SLE) who were not selected on the basis of features of antiphospholipid syndrome. Clinical and laboratory associations of increased levels of anticardiolipin antibodies were evaluated. IgG and IgM antibodies to cardiolipin were documented in 224 (60.9%) and 128 (34.8%) patients, respectively. Regarding the symptoms of antiphospholipid syndrome, elevated amounts of anticardiolipin IgG were significantly associated with spontaneous abortion (P<0.001), thrombocytopenia (P<0.01), livedo reticularis (P<0.01) and a positive direct Coombs test (P<0.05), but not with thrombosis or central nervous system diseases such as epilepsy and psychosis. IgM antibodies to cardiolipin were associated with a positive direct Coombs test (P<0.01), but with no other symptom of antiphospholipid syndrome. The predictive values of anticardiolipin antibody determinations in unselected SLE patients were poor for all features of antiphospholipid syndrome because of high proportions of false-positive and false-negative results. As for other manifestations of SLE, positive correlations between raised antibodies to double-stranded DNA and the occurrence of anticardiolipin antibodies of the IgG isotype were observed, and anticardiolipin IgM was negatively associated with nephritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271–1277

    Google Scholar 

  2. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Domenech I, Aydintug AO, Jedryka-Goral A, DeRamon E, Galeazzi M, Haga HJ, Mathieu A, Houssiau F, Ingelmo M, Hughes GRV (1993) Systemic lupus erythematosus: clinical and immunologie patterns of disease expression in a cohort of 1,000 patients. Medicine 72: 113–124

    Google Scholar 

  3. Hughes GRV (1988) Systemic lupus erythematosus. Postgrad Med J 64: 515–521

    Google Scholar 

  4. Hughes GRV (1983) Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. BMJ 287: 1088–1089

    Google Scholar 

  5. Fort JG, Cowchock FS, Abruzzo JL, Smith JB (1987) Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum 30: 752–760

    Google Scholar 

  6. Manoussakis MN, Gharavi AE, Drosos AA, Kitridou RC, Moutsopoulous HM (1987) Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. Clin Immunol Immunopathol 44: 297–307

    Google Scholar 

  7. Manoussakis MN, Tzioufas AG, Silis MP, Pange PJ, Goudevenos J, Moutsopoulous HM (1987) High prevalence of anticardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 69: 557–565

    Google Scholar 

  8. Love PE, Santoro SA (1990) Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 112: 682–698

    Google Scholar 

  9. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou SV, Hughes GRV (1983) Anti-cardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet II: 1211–1214

    Google Scholar 

  10. Harris EN, Chan JKH, Asherson RA, Aber VR, Gharavi AE, Hughes GRV (1986) Thrombosis, recurrent fetal loss, and thrombocytopenia: predictive value of the anticardiolipin antibody test. Arch Intern Med 146: 2153–2156

    Google Scholar 

  11. Kalunian KC, Peter JB, Middlekauff HR, Sayre J, Ando DG, Mangotich M, Hahn BH (1988) Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Am J Med 85: 602–608

    Google Scholar 

  12. Wang Y, Schrieber L, Cohen MG, Furphy L, Webb J, Chivers T, Pollard KM (1990) Antiphospholipid antibodies in systemic lupus erythematosus: clinical and laboratory associations in 111 patients. Rheumatol Int 10: 75–80

    Google Scholar 

  13. Gulko PS, Reveille JD, Koopman WJ, Burgard SL, Bartolucci AA, Alarcon GS (1993) Anticardiolipin antibodies in systemic lupus erythematosus: clinical correlates, HLA associations, and impact on survival. J Rheumatol 20: 1684–1693

    Google Scholar 

  14. Derue G, Englert H, Harris EN (1985) Fetal loss in systemic lupus: association with anticardiolipin antibodies. J Obstet Gynecol Neonatal Nurs 5: 207–209

    Google Scholar 

  15. Lockshin MD, Druzin ML, Goei S, Qamar T, Magid MS, Jovanovic L, Ferenc M (1985) Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 313: 152–156

    Google Scholar 

  16. Cronin ME, Biswas RM, VanderStraeton C, Fleisher TA, Klippel JH (1988) IgG and IgM anticardiolipin antibodies in patients with lupus with anticardiolipin antibody associated clinical syndromes. J Rheumatol 15: 795–798

    Google Scholar 

  17. Loizou S, Byron MA, Englert HJ, David J, Hughes GRV (1988) Association of quantitative anticardiolipin antibody levels with fetal loss in systemic lupus erythematosus. Q J Med 255: 525–531

    Google Scholar 

  18. Kutteh WH, Lyda EC, Abraham SM, Wacholtz MC (1993) Association of anticardiolipin antibodies and pregnancy loss in women with systemic lupus erythematosus. Fertil Steril 60: 449–455

    Google Scholar 

  19. Harris EN, Asherson RA, Gharavi AE, Morgan SH, DeRue G, Hughes GRV (1985) Thrombocytopenia in SLE and related autoimmune disorders. Association with anticardiolipin antibody. Br J Haematol 59: 227–230

    Google Scholar 

  20. Weidmann CE, Wallace DJ, Peter JB, Knight PJ, Bear MB, Klinenberg JR (1988) Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus. J Rheumatol 15: 74–79

    Google Scholar 

  21. Weinstein C, Miller MH, Axtens R, Buchanan R, Littlejohn GO (1987) Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus. Arch Dermatol 123: 596–600

    Google Scholar 

  22. Shergy WJ, Kredich DW, Pisetsky DS (1988) The relationship of anticardiolipin antibodies to disease manifestation in pediatric systemic lupus erythematosus. J Rheumatol 15: 1389–1394

    Google Scholar 

  23. Sturfelt G, Nived O, Norberg R, Thorstensson R, Krook K (1987) Anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 30: 382–388

    Google Scholar 

  24. Harris EN, Gharavi AE, Patel SP, Hughes GRV (1987) Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 68: 215–222

    Google Scholar 

  25. Feinstein DI (1985) Lupus anticoagulant, thrombosis, and fetal loss. N Engl J Med 313: 1348–1350

    Google Scholar 

  26. Hughes GRV, Asherson RA, Khamashata MA (1989) The antiphospholipid syndrome-from theory to discovery. Postgrad Med J 65: 691–704

    Google Scholar 

  27. Habscheid W, Brauer P (1992) Diagnostik und klinische Bedeutung von Antiphospholipid-Antikörpern. Dtsch Med Wochenschr 117: 549–554

    Google Scholar 

  28. Asherson RA, Cervera R (1993) Antiphospholipid syndrome. J Invest Dermatol 100: 21S-27S

    Google Scholar 

  29. Khamashta MA, Hughes GRV (1993) Antiphospholipid syndrome. BMJ 307: 883–884

    Google Scholar 

  30. Meyer O, Cyna L, Bourgeois P, Kahn MF, Ryckewaert A (1987) Profile and cross-reactivities of antiphospholipid antibodies in systemic lupus erythematosus and syphilis. Clin Rheumatol 6: 369–377

    Google Scholar 

  31. Mackworth-Young C (1990) Antiphospholipid antibodies: more than just a disease marker? Immunol Today 11: 60–65

    Google Scholar 

  32. Smeenk RJT, Lucassen WAM, Swaak TJ (1987) Is anticardiolipin activity a cross-reaction of anti-DNA or a separate entity? Arthritis Rheum 30: 607–617

    Google Scholar 

  33. Rauch J, Tannenbaum H, Stollar BD, Schwartz RS (1984) Monoclonal anticardiolipin antibodies bind to DNA. Eur J Immunol 14: 529–534

    Google Scholar 

  34. Eilat D, Zlotnick AY, Fischel R (1986) Evaluation of the cross-reaction between anti-DNA and anti-cardiolipin antibodies in SLE experimental animals. Clin Exp Immunol 65: 269–278

    Google Scholar 

  35. Harris EN, Gharavi AE, Loizou S, Derue G, Chan JK, Patel BM, Mackworth-Young CG, Bunn CC, Hughes GRV (1985) Crossreactivity of antiphospholipid antibodies. J Clin Lab Immunol 16: 1–6

    Google Scholar 

  36. Ishii Y, Nagasawa K, Mayumi T, Niho Y (1990) Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematosus. Ann Rheum Dis 49: 387–390

    Google Scholar 

  37. Branch DW, Scott JR, Kochenour NK, Heashgold E (1985) Obstetric complications associated with the lupus anticoagulant. N Engl J Med 313: 1322–1326

    Google Scholar 

  38. Gatenby PA, Cameron K, Shearman RP (1989) Pregnancy loss with anticardiolipin antibodies. Improved outcome with aspirin containing treatment. Aust N Z J Obstet Gynaecol 29: 294–298

    Google Scholar 

  39. Rosove MH, Tabsh K, Howard P, Wasserstrum N, Brinkman CR (1987) Heparin therapy for prevention of fetal wastage in women with anticardiolipin antibodies and lupus anticoagulants (abstract). Blood 70: 379

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sachse, C., Lüthke, K., Hartung, K. et al. Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations. Rheumatol Int 15, 23–29 (1995). https://doi.org/10.1007/BF00286765

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00286765

Key words

Navigation